Shorepoint Capital Partners LLC Merck & Co., Inc. Transaction History

Shorepoint Capital Partners LLC

$426 Million
Q3 2024

A detailed history of Shorepoint Capital Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Shorepoint Capital Partners LLC holds 46,202 shares of MRK stock, worth $4.59 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

46,202

Previous 47,868 3.48%

Holding current value

$4.59 Million

Previous $5.93 Million 11.47%

% of portfolio

1.23%

Previous 1.42%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $185,175 - $214,864	-1,666 Reduced 3.48%	46,202 $5.25 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $20,179 - $21,672	163 Added 0.34%	47,868 $5.93 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $169,520 - $197,529	-1,497 Reduced 3.04%	47,705 $6.29 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $5,309 - $5,778	53 Added 0.11%	49,202 $5.36 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $39,326 - $43,674	-382 Reduced 0.77%	49,149 $5.06 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $156,832 - $170,940	-1,444 Reduced 2.83%	49,531 $5.72 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $1.05 Million - $1.17 Million	-10,218 Reduced 16.7%	50,975 $5.42 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $492,462 - $631,403	5,632 Added 10.14%	61,193 $6.79 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $66,947 - $75,208	792 Added 1.45%	55,561 $4.79 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $109,956 - $124,640	-1,317 Reduced 2.35%	54,769 $4.99 Million
Q1 2022 May 09, 2022	SELL	$73.51 - $82.4 $55,058 - $61,717	-749 Reduced 1.32%	56,086 $4.6 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $51,318 - $64,283	710 Added 1.27%	56,835 $4.36 Million
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $790,845 - $869,731	11,033 Added 24.47%	56,125 $4.22 Million
Q1 2021 May 10, 2021	BUY	$68.86 - $81.11 $590,749 - $695,842	8,579 Added 23.5%	45,092 $3.48 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $81,746 - $90,721	1,139 Added 3.22%	36,513 $2.99 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $204,025 - $231,264	2,788 Added 8.56%	35,374 $2.93 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $9,647 - $10,977	137 Added 0.42%	32,586 $2.52 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $1,710 - $2,371	-27 Reduced 0.08%	32,449 $2.5 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $302,406 - $341,230	-3,898 Reduced 10.72%	32,476 $2.95 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $101,110 - $110,213	-1,329 Reduced 3.52%	36,374 $3.06 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $173,203 - $202,343	-2,480 Reduced 6.17%	37,703 $3.16 Million
Q1 2019 Apr 12, 2019	BUY	$69.58 - $79.36 $2.8 Million - $3.19 Million	40,183 New	40,183 $3.34 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shorepoint Capital Partners LLC with notifications on news.

Account

Shorepoint Capital Partners LLC Merck & Co., Inc. Transaction History